It also means that the worry of a near term capital raise is taken off the table. I think the stock price shows that everyone knows there will be a raise and that is priced in. I'm not saying there won't be a drop but i don't think it will be as severe as past raises. CYDY is moving forward no matter what and unfortunately it has been at our expense. the end game is the same and the multiples are still there. i hope.
Agree, and that is why I don't think it will happen. IMHO Paulson will not go to its "investor well" again, unless something very positive occurs. I expect some type of a "deal" to be done this Summer, perhaps licensing in exchange for comprehensive Clinical Trial Funding by BP. Given CYDY's current circumstances and history, a licensing deal makes sense for all parties. Disclosure: I am a longtime investor in the company.
News 
Market Data 
Discover 
AI
